ARTICLE | Clinical News
HS-tk vector: Will treat up to 24 patients in an on-going Phase I/II trial
August 22, 1994 7:00 AM UTC
Genetic Therapy Inc. (GTII), Gaithersburg, Md. Product: HS-tk vector to transfer the gene for thymidine kinase, which renders tumor cells susceptible to the anti-viral drug ganciclovir Indication: Lep...